US FDA grants standard approval of Eisai/Biogen Alzheimer’s drug
By Deena Beasley and Julie Steenhuysen LOS ANGELES (Reuters) -Eisai and Biogen’s Leqembi won a...
By Deena Beasley and Julie Steenhuysen LOS ANGELES (Reuters) -Eisai and Biogen’s Leqembi won a...
By Ludwig Burger FRANKFURT (Reuters) – Novartis breast cancer drug Kisqali cut the risk of...
By Brendan Pierson (Reuters) -Johnson & Johnson on Wednesday faced the first trial in almost...
(Reuters) -Pfizer Inc is planning to raise $31 billion through its largest debt offering to...
By Michael Erman (Reuters) -Merck & Co said on Sunday it will buy Prometheus Biosciences...
By Sheila Dang (Reuters) – Twitter-owner Elon Musk has said advertisers are returning to the...
By Dietrich Knauth and Mike Spector (Reuters) -Johnson & Johnson’s second attempt to resolve talc...
By Julie Steenhuysen CHICAGO (Reuters) – The U.S. National Institute on Aging (NIA) is funding...